Guilin Sanjin (002275.SZ) stated during an investor relations event on June 20th that the company's first quarter performance declined compared to the same period last year mainly due to the impact of a public health event during the same period last year, which resulted in a significant increase in sales for the current period as a result of normal market supply. At the same time, excluding the impact of special circumstances from the first quarter of last year, the sales volume for the first quarter of 24, 22, 21 and previous years is also at a high level compared to the same period. The company also announced its budget for this year and aims to accomplish this year's tasks according to the budget for the whole year.
桂林三金(002275.SZ)：从全年来看，公司力争按照预算数完成今年的任务
Guilin Sanjin Pharmaceutical (002275.SZ): From the perspective of the whole year, the company strives to complete this year's tasks according to the budget.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.